RXRβ inhibitors represent a class of chemical compounds meticulously crafted for their precise role in modulating the activity of the Retinoid X Receptor Beta (RXRβ). RXRβ, as a nuclear receptor, is a fundamental component of the regulatory machinery governing gene expression. These inhibitors are engineered to exert their effects by strategically intervening in the functioning of RXRβ, often through mechanisms that encompass the obstruction of its activation or the reshaping of its structural conformation. These inhibitors play a pivotal role in molecular biology research by enabling scientists to probe the intricate landscape of nuclear receptor signaling pathways. RXRβ is a central player in this network, forming heterodimeric complexes with various other nuclear receptors. This includes associations with retinoic acid receptors (RARs), peroxisome proliferator-activated receptors (PPARs), liver X receptors (LXRs), among others. RXRβ inhibitors are designed to disrupt these crucial heterodimeric interactions, effectively preventing the activation of downstream genes that are typically regulated by these receptor complexes.
Chemically, RXRβ inhibitors encompass a wide spectrum of structural diversity. Some are synthetic retinoids, mimicking the natural ligands of RXRβ, while others are innovative synthetic molecules purposefully tailored to selectively engage with and modulate RXRβ activity. These compounds often possess specific functional groups and structural motifs that facilitate their interaction with distinct regions of the RXRβ protein, thereby interrupting its ability to bind with partner receptors or coactivators. RXRβ inhibitors have emerged as indispensable tools in deciphering the underlying molecular mechanisms of gene regulation. Their application in scientific research allows for a deeper understanding of how cells control gene expression. These compounds, with their intricate design and precise targeting, empower researchers to explore the fundamental processes governing cellular biology and gene regulation at a molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LG 100268 | 153559-76-3 | sc-211737 | 5 mg | $390.00 | 2 | |
LG100268 is a synthetic retinoid compound that acts as a potent RXRβ agonist. | ||||||
Bexarotene | 153559-49-0 | sc-217753 sc-217753A | 10 mg 100 mg | $55.00 $250.00 | 6 | |
Bexarotene is a synthetic retinoid that functions as a selective RXRβ agonist. | ||||||
UVI 3003 | 847239-17-2 | sc-358586 sc-358586A | 10 mg 50 mg | $168.00 $714.00 | 5 | |
UVI3003 is another synthetic compound that acts as an RXRβ antagonist. It has been explored for its potential in cancer research. | ||||||
MM 11253 | 345952-44-5 | sc-361255 sc-361255A | 10 mg 50 mg | $477.00 $2040.00 | 2 | |
MM11253 is a compound that acts as a selective RXRβ antagonist. It has been investigated in the context of cancer research. | ||||||
SR 11237 | 146670-40-8 | sc-296418 sc-296418A | 5 mg 50 mg | $211.00 $877.00 | ||
SR11237 is a synthetic compound that acts as a dual inhibitor of both RXRβ and PPARγ (Peroxisome Proliferator-Activated Receptor Gamma). | ||||||